Eli Lilly Q3 Non-GAAP Earnings, Revenue Increase; 2026 Guidance Updated

07:19 AM EDT, 10/29/2026 (MT Newswires) -- Eli Lilly (LLY) reported Q3 non-GAAP earnings Thursday of $7.48 per diluted share, up from $7.02 a year earlier. Analysts polled by FactSet expected $5.68. Revenue for the quarter ended Sept. 30 was $24.40 billion, up from $17.60 billion a year earlier. Analysts expected $22.58 billion. For 2026, the company lowered its non-GAAP earnings guidance range to between $35 and $36, down from $35.50 to $36.50, and raised its revenue guidance to between $91 billion and $92 billion, up from $85 billion to $87 billion. Analysts expect $33.76 and $88.82 billion, respectively. Shares of the company were up 4% in recent Thursday premarket activity.